Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDRY.L Regulatory News (SDRY)

  • There is currently no data for SDRY

Form 8.3 - Superdry plc

28 Feb 2024 14:58

RNS Number : 8359E
Legal & General Inv Mgmt (Holdings)
28 February 2024

FORM 8.3

PUBLIC DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:

Legal And General Investment Management (Holdings) Ltd.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Legal And General Investment Management (Holdings) Ltd.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Superdry plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

No

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

27 February 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

ORD GBP 0.05

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,100,595

1.11%

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

1,100,595

1.11%

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

ORD GBP 0.05

Purchase

6,300

GBP 0.3875

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

./

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

28 February 2024

Contact name:

Laszlo Benedek

Telephone number:

029 2011 4065

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETQKFBPQBKDOBB
Date   Source Headline
14th Feb 202011:58 amRNSDirector/PDMR Shareholding
31st Jan 20203:42 pmRNSTotal Voting Rights
28th Jan 20202:25 pmRNSDirector Declaration
28th Jan 20209:18 amRNSDirector/PDMR Shareholding
20th Jan 20203:35 pmRNSDirector/PDMR Shareholding
14th Jan 20209:40 amRNSDirector/PDMR Shareholding
10th Jan 20207:00 amRNSTrading Statement
31st Dec 201912:23 pmRNSTotal Voting Rights
23rd Dec 20193:57 pmRNSHolding(s) in Company
19th Dec 20199:51 amRNSDirector/PDMR Shareholding
16th Dec 201911:13 amRNSDirector/PDMR Shareholding
12th Dec 20197:00 amRNSHalf-year Report
29th Nov 20199:51 amRNSTotal Voting Rights
15th Nov 201911:00 amRNSDirector/PDMR Shareholding
14th Nov 201910:45 amRNSHolding(s) in Company
7th Nov 20197:00 amRNSPre-Close Trading Statement
31st Oct 201910:26 amRNSTotal Voting Rights
28th Oct 201911:32 amRNSDirector Declaration
18th Oct 20199:02 amRNSHolding(s) in Company
15th Oct 20199:37 amRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSStatement re Chief Executive Officer
30th Sep 20199:10 amRNSTotal Voting Rights
25th Sep 201911:15 amRNSDirector/PDMR Shareholding
25th Sep 201911:14 amRNSDirector/PDMR Shareholding
24th Sep 201910:10 amRNSDirector/PDMR Shareholding
24th Sep 20199:41 amRNSHolding(s) in Company
23rd Sep 20199:09 amRNSBlock listing Interim Review
16th Sep 201911:03 amRNSDirector/PDMR Shareholding
11th Sep 20191:17 pmRNSResult of AGM
30th Aug 201911:34 amRNSTotal Voting Rights
16th Aug 20199:54 amRNSDirector Declaration
16th Aug 20199:43 amRNSDirector/PDMR Shareholding
15th Aug 20199:33 amRNSDirector/PDMR Shareholding
13th Aug 201911:07 amRNSStatement re Chief Financial Officer
13th Aug 20199:07 amRNSStatement re Appointment of Corporate Broker
9th Aug 20199:52 amRNSAnnual Report and Notice of AGM
7th Aug 201910:27 amRNSDirector/PDMR Shareholding
31st Jul 201911:16 amRNSTotal Voting Rights
26th Jul 20197:00 amRNSNon-Executive Director Appointments
17th Jul 20199:59 amRNSHolding(s) in Company
16th Jul 20191:23 pmRNSDirector/PDMR Shareholding
15th Jul 20193:51 pmRNSDirector/PDMR Shareholding
10th Jul 201912:25 pmRNSFinal Dividend Record Date Correction
10th Jul 20197:00 amRNSFinal Results
4th Jul 20197:00 amRNSDirectorate Change
28th Jun 201911:10 amRNSTotal Voting Rights
27th Jun 20197:00 amRNSNotice of Preliminary Results
14th Jun 20197:59 amRNSDirector/PDMR Shareholding
4th Jun 201912:27 pmRNSDirector Declaration
3rd Jun 201912:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.